compared to an dose of 225 PK - * To (dose the dose in response women of Rekovelle with respect to ovarian response in trial IVF/ICSI Healthy See PK subjects separate report Target trial. * Indicates the primary PK aim of the study. Bioequivalence of different formulations. † Table 2A: Pharmacokinetic results excluded from consideration. Study ID Subtopics PK results excluded CS03 Single dose PK Other PK studies evaluated. Although Australia has in Japanese and some Japanese women, the other studies were more Caucasian relevant to our population Summary of pharmacokinetics Physicochemical characteristics of the active substance The Rekovelle drug substance is a clear or slightly turbid colourless solution. The pH range of Rekovelle drug substance is 6.2-7.5. Rekovelle (33.3µg/mL) is a sterile aqueous solution is supplied in a cartridge with the active drug product and excipients.
compared to an dose of 225 PK (dose in women - * To the dose response of Rekovelle with respect to ovarian response in IVF/ICSI PK Healthy subjects See separate report Target * Indicates the primary PK aim of the study. † Bioequivalence of different formulations. Table 2A: Pharmacokinetic results excluded from consideration. Study ID Subtopics PK results excluded CS03 Single dose PK in Japanese and Caucasian Other PK studies evaluated. Although Australia has some Japanese women, the other studies were more relevant to our population Summary of pharmacokinetics Physicochemical characteristics of the active substance The Rekovelle drug substance is a clear or slightly turbid colourless solution. The pH range of Rekovelle drug substance is 6.2-7.5. Rekovelle (33.3µg/mL) is a sterile aqueous solution is supplied in a cartridge with the active drug product and excipients. trial. trial